 Emily McCourt
Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinopathy of Prematurity | 12 | 2024 | 142 | 2.760 |
Why?
| | Keratoconus | 4 | 2025 | 23 | 2.710 |
Why?
| | Cornea | 3 | 2025 | 138 | 1.880 |
Why?
| | Down Syndrome | 5 | 2025 | 497 | 1.420 |
Why?
| | Corneal Topography | 4 | 2025 | 24 | 1.390 |
Why?
| | Cataract | 6 | 2025 | 213 | 1.270 |
Why?
| | Corneal Diseases | 3 | 2018 | 35 | 1.220 |
Why?
| | Tomography | 2 | 2025 | 40 | 1.150 |
Why?
| | Anesthesia, General | 2 | 2025 | 77 | 1.100 |
Why?
| | Conjunctival Diseases | 2 | 2017 | 18 | 1.070 |
Why?
| | Visual Acuity | 6 | 2025 | 356 | 1.070 |
Why?
| | Eye Injuries | 2 | 2018 | 45 | 0.980 |
Why?
| | Cataract Extraction | 3 | 2025 | 98 | 0.940 |
Why?
| | Retinal Diseases | 2 | 2025 | 91 | 0.890 |
Why?
| | Neonatal Screening | 5 | 2022 | 169 | 0.890 |
Why?
| | Patient Positioning | 1 | 2025 | 67 | 0.880 |
Why?
| | Pyrimidinones | 1 | 2025 | 113 | 0.870 |
Why?
| | Birth Weight | 9 | 2024 | 516 | 0.830 |
Why?
| | Pyridones | 1 | 2025 | 168 | 0.820 |
Why?
| | Cranial Nerve Diseases | 2 | 2020 | 42 | 0.820 |
Why?
| | Epithelium, Corneal | 2 | 2024 | 41 | 0.800 |
Why?
| | Eye Diseases | 2 | 2020 | 87 | 0.750 |
Why?
| | Pontine Tegmentum | 1 | 2020 | 4 | 0.700 |
Why?
| | Cerebellar Diseases | 1 | 2020 | 23 | 0.680 |
Why?
| | Stevens-Johnson Syndrome | 2 | 2018 | 39 | 0.660 |
Why?
| | Nervous System Malformations | 1 | 2020 | 42 | 0.660 |
Why?
| | Infant, Very Low Birth Weight | 4 | 2019 | 68 | 0.660 |
Why?
| | Retrospective Studies | 26 | 2025 | 15682 | 0.650 |
Why?
| | Infant | 21 | 2025 | 9482 | 0.640 |
Why?
| | Child, Preschool | 13 | 2025 | 11105 | 0.620 |
Why?
| | Retinal Detachment | 2 | 2025 | 63 | 0.620 |
Why?
| | Gestational Age | 12 | 2024 | 910 | 0.610 |
Why?
| | Protein Kinase Inhibitors | 1 | 2025 | 916 | 0.600 |
Why?
| | Vitrectomy | 1 | 2018 | 70 | 0.570 |
Why?
| | Serum | 1 | 2018 | 59 | 0.570 |
Why?
| | Ophthalmic Solutions | 1 | 2018 | 75 | 0.570 |
Why?
| | Developmental Disabilities | 1 | 2020 | 264 | 0.560 |
Why?
| | Farber Lipogranulomatosis | 1 | 2017 | 4 | 0.550 |
Why?
| | Infant, Low Birth Weight | 2 | 2017 | 141 | 0.540 |
Why?
| | Coccyx | 1 | 2017 | 4 | 0.540 |
Why?
| | Amnion | 1 | 2017 | 28 | 0.530 |
Why?
| | Synovitis | 1 | 2017 | 28 | 0.530 |
Why?
| | Choroid Neoplasms | 1 | 2017 | 7 | 0.530 |
Why?
| | Infant, Newborn | 15 | 2024 | 6084 | 0.530 |
Why?
| | Cicatrix | 1 | 2017 | 64 | 0.510 |
Why?
| | Sacrum | 1 | 2017 | 67 | 0.510 |
Why?
| | Arthritis | 1 | 2017 | 96 | 0.510 |
Why?
| | Tomography, Optical Coherence | 2 | 2025 | 213 | 0.500 |
Why?
| | Uveitis | 1 | 2017 | 137 | 0.490 |
Why?
| | Teratoma | 1 | 2017 | 114 | 0.480 |
Why?
| | Infant, Premature, Diseases | 1 | 2017 | 101 | 0.480 |
Why?
| | Child | 18 | 2025 | 21989 | 0.460 |
Why?
| | Glaucoma | 3 | 2025 | 237 | 0.450 |
Why?
| | Algorithms | 4 | 2018 | 1704 | 0.440 |
Why?
| | Bone Neoplasms | 1 | 2017 | 247 | 0.440 |
Why?
| | Hyphema | 1 | 2013 | 4 | 0.430 |
Why?
| | Adolescent | 12 | 2025 | 21574 | 0.410 |
Why?
| | Female | 31 | 2025 | 73465 | 0.400 |
Why?
| | Humans | 48 | 2025 | 137782 | 0.390 |
Why?
| | Colorado | 10 | 2023 | 4576 | 0.380 |
Why?
| | Cryoglobulinemia | 1 | 2012 | 5 | 0.380 |
Why?
| | Vision, Low | 1 | 2012 | 16 | 0.370 |
Why?
| | Retinal Vasculitis | 1 | 2012 | 10 | 0.370 |
Why?
| | Male | 26 | 2025 | 67906 | 0.370 |
Why?
| | Infant, Premature | 5 | 2022 | 574 | 0.370 |
Why?
| | Dacryocystitis | 1 | 2010 | 3 | 0.340 |
Why?
| | Mucocele | 1 | 2010 | 12 | 0.340 |
Why?
| | Choroid | 1 | 2010 | 62 | 0.330 |
Why?
| | Eye Infections, Bacterial | 1 | 2010 | 28 | 0.330 |
Why?
| | Retinal Neoplasms | 1 | 2010 | 25 | 0.330 |
Why?
| | Endophthalmitis | 1 | 2010 | 29 | 0.330 |
Why?
| | Retinoblastoma | 1 | 2010 | 32 | 0.330 |
Why?
| | Cytomegalovirus Retinitis | 2 | 2022 | 21 | 0.320 |
Why?
| | Risk Factors | 11 | 2024 | 10407 | 0.320 |
Why?
| | Ophthalmology | 2 | 2022 | 86 | 0.320 |
Why?
| | Hepatitis C, Chronic | 1 | 2012 | 164 | 0.320 |
Why?
| | Porencephaly | 2 | 2019 | 6 | 0.320 |
Why?
| | Fluorescein Angiography | 2 | 2025 | 151 | 0.310 |
Why?
| | Streptococcus agalactiae | 1 | 2010 | 93 | 0.310 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2010 | 137 | 0.300 |
Why?
| | Macular Degeneration | 1 | 2010 | 164 | 0.300 |
Why?
| | Incidence | 5 | 2022 | 2804 | 0.290 |
Why?
| | Diabetic Retinopathy | 1 | 2010 | 189 | 0.290 |
Why?
| | Streptococcal Infections | 1 | 2010 | 151 | 0.290 |
Why?
| | Diagnostic Techniques, Ophthalmological | 2 | 2018 | 40 | 0.270 |
Why?
| | Aphakia, Postcataract | 1 | 2025 | 1 | 0.240 |
Why?
| | Weight Gain | 3 | 2019 | 519 | 0.240 |
Why?
| | Microscopy, Acoustic | 2 | 2018 | 8 | 0.240 |
Why?
| | Riboflavin | 1 | 2025 | 13 | 0.230 |
Why?
| | Corneal Stroma | 1 | 2025 | 23 | 0.230 |
Why?
| | Photosensitizing Agents | 1 | 2025 | 41 | 0.230 |
Why?
| | Photochemotherapy | 1 | 2025 | 44 | 0.230 |
Why?
| | Young Adult | 6 | 2025 | 13240 | 0.220 |
Why?
| | Cross-Linking Reagents | 1 | 2025 | 217 | 0.220 |
Why?
| | Tertiary Care Centers | 1 | 2025 | 160 | 0.220 |
Why?
| | Specialties, Surgical | 1 | 2025 | 75 | 0.210 |
Why?
| | Lens, Crystalline | 1 | 2025 | 125 | 0.210 |
Why?
| | Amblyopia | 1 | 2023 | 8 | 0.210 |
Why?
| | Vision Screening | 1 | 2023 | 9 | 0.210 |
Why?
| | Diseases in Twins | 1 | 2024 | 169 | 0.210 |
Why?
| | Corneal Injuries | 1 | 2024 | 44 | 0.210 |
Why?
| | Refractive Errors | 1 | 2023 | 18 | 0.210 |
Why?
| | Ophthalmologists | 1 | 2023 | 12 | 0.210 |
Why?
| | Physicians, Women | 1 | 2025 | 83 | 0.210 |
Why?
| | Xanthomatosis, Cerebrotendinous | 1 | 2023 | 4 | 0.210 |
Why?
| | Galactosemias | 1 | 2023 | 16 | 0.210 |
Why?
| | Twins | 1 | 2024 | 243 | 0.200 |
Why?
| | Arachnoid Cysts | 1 | 2023 | 7 | 0.200 |
Why?
| | Milk, Human | 1 | 2024 | 158 | 0.190 |
Why?
| | Collagen | 1 | 2025 | 452 | 0.190 |
Why?
| | Collagen Type IV | 2 | 2019 | 28 | 0.190 |
Why?
| | Papilledema | 1 | 2023 | 39 | 0.190 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 853 | 0.180 |
Why?
| | Physical Examination | 2 | 2023 | 241 | 0.180 |
Why?
| | Ophthalmoscopy | 2 | 2018 | 36 | 0.180 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2022 | 127 | 0.180 |
Why?
| | Wound Healing | 1 | 2024 | 331 | 0.180 |
Why?
| | Mice, Inbred BALB C | 1 | 2024 | 1272 | 0.180 |
Why?
| | Vigabatrin | 1 | 2021 | 19 | 0.180 |
Why?
| | Surgeons | 1 | 2025 | 297 | 0.170 |
Why?
| | Corneal Pachymetry | 1 | 2020 | 15 | 0.170 |
Why?
| | Hospitals, Pediatric | 2 | 2023 | 509 | 0.170 |
Why?
| | Cytomegalovirus | 2 | 2022 | 157 | 0.170 |
Why?
| | Mutation | 4 | 2019 | 3959 | 0.160 |
Why?
| | Cross-Sectional Studies | 4 | 2025 | 5478 | 0.160 |
Why?
| | ROC Curve | 2 | 2019 | 554 | 0.160 |
Why?
| | Legislation, Drug | 1 | 2020 | 80 | 0.160 |
Why?
| | Specialization | 1 | 2020 | 144 | 0.150 |
Why?
| | Remission, Spontaneous | 1 | 2019 | 40 | 0.150 |
Why?
| | Retinal Hemorrhage | 1 | 2019 | 19 | 0.150 |
Why?
| | Anticonvulsants | 1 | 2021 | 217 | 0.150 |
Why?
| | Cohort Studies | 6 | 2020 | 5750 | 0.150 |
Why?
| | Face | 1 | 2020 | 173 | 0.150 |
Why?
| | Intracranial Pressure | 1 | 2019 | 57 | 0.150 |
Why?
| | Medical Marijuana | 1 | 2020 | 117 | 0.140 |
Why?
| | Intracranial Hypertension | 1 | 2019 | 40 | 0.140 |
Why?
| | Fluorometholone | 1 | 2017 | 4 | 0.140 |
Why?
| | Perception | 1 | 2020 | 359 | 0.140 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 189 | 0.140 |
Why?
| | Fetal Membranes, Premature Rupture | 1 | 2017 | 37 | 0.130 |
Why?
| | North America | 1 | 2018 | 313 | 0.130 |
Why?
| | Labor, Induced | 1 | 2017 | 33 | 0.130 |
Why?
| | Nod2 Signaling Adaptor Protein | 1 | 2017 | 34 | 0.130 |
Why?
| | Electronic Health Records | 1 | 2025 | 1070 | 0.130 |
Why?
| | Labor, Obstetric | 1 | 2017 | 61 | 0.130 |
Why?
| | Marijuana Smoking | 1 | 2020 | 256 | 0.130 |
Why?
| | Marijuana Use | 1 | 2020 | 206 | 0.130 |
Why?
| | Cell Proliferation | 1 | 2024 | 2475 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 584 | 0.120 |
Why?
| | Burnout, Professional | 1 | 2022 | 442 | 0.120 |
Why?
| | Household Products | 1 | 2015 | 6 | 0.120 |
Why?
| | Adult | 7 | 2025 | 38023 | 0.120 |
Why?
| | Mothers | 2 | 2018 | 759 | 0.120 |
Why?
| | Eye Burns | 1 | 2015 | 12 | 0.120 |
Why?
| | Xerophthalmia | 1 | 2014 | 7 | 0.120 |
Why?
| | Sarcoidosis | 1 | 2017 | 160 | 0.120 |
Why?
| | Vitamin A Deficiency | 1 | 2014 | 26 | 0.110 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 319 | 0.110 |
Why?
| | Burns, Chemical | 1 | 2015 | 32 | 0.110 |
Why?
| | Corneal Ulcer | 1 | 2014 | 16 | 0.110 |
Why?
| | Vitamin B 12 Deficiency | 1 | 2015 | 81 | 0.110 |
Why?
| | DNA, Viral | 1 | 2016 | 364 | 0.110 |
Why?
| | Homocystinuria | 1 | 2015 | 71 | 0.110 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4295 | 0.110 |
Why?
| | Accidents, Home | 1 | 2013 | 31 | 0.110 |
Why?
| | Sensitivity and Specificity | 4 | 2023 | 1946 | 0.100 |
Why?
| | Telangiectasis | 1 | 2013 | 7 | 0.100 |
Why?
| | Skin Diseases, Vascular | 1 | 2013 | 9 | 0.100 |
Why?
| | Premature Birth | 1 | 2017 | 333 | 0.100 |
Why?
| | Physicians | 1 | 2022 | 914 | 0.100 |
Why?
| | Treatment Outcome | 4 | 2025 | 10837 | 0.100 |
Why?
| | Glucocorticoids | 1 | 2017 | 596 | 0.100 |
Why?
| | DNA | 1 | 2019 | 1459 | 0.090 |
Why?
| | Placenta | 1 | 2018 | 750 | 0.090 |
Why?
| | Intraocular Pressure | 1 | 2013 | 307 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 3 | 2019 | 3577 | 0.090 |
Why?
| | Fovea Centralis | 1 | 2010 | 11 | 0.090 |
Why?
| | Time Factors | 2 | 2019 | 6834 | 0.090 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2016 | 622 | 0.090 |
Why?
| | Eye Enucleation | 1 | 2010 | 12 | 0.080 |
Why?
| | Postoperative Complications | 2 | 2025 | 2659 | 0.080 |
Why?
| | Decompression, Surgical | 1 | 2010 | 106 | 0.080 |
Why?
| | Functional Laterality | 1 | 2010 | 223 | 0.080 |
Why?
| | Inflammation | 1 | 2018 | 2838 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2010 | 1483 | 0.060 |
Why?
| | Pseudophakia | 1 | 2025 | 12 | 0.060 |
Why?
| | Nystagmus, Pathologic | 1 | 2025 | 13 | 0.060 |
Why?
| | Strabismus | 1 | 2025 | 29 | 0.060 |
Why?
| | Refraction, Ocular | 1 | 2025 | 37 | 0.060 |
Why?
| | Myopia | 1 | 2025 | 47 | 0.060 |
Why?
| | Laser Coagulation | 2 | 2017 | 68 | 0.060 |
Why?
| | Re-Epithelialization | 1 | 2024 | 7 | 0.060 |
Why?
| | Cholestanol | 1 | 2023 | 3 | 0.050 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2024 | 346 | 0.050 |
Why?
| | Rupture | 1 | 2023 | 92 | 0.050 |
Why?
| | Ganciclovir | 1 | 2022 | 53 | 0.050 |
Why?
| | Ultraviolet Rays | 1 | 2025 | 396 | 0.050 |
Why?
| | Follow-Up Studies | 2 | 2025 | 5136 | 0.050 |
Why?
| | United States | 4 | 2022 | 14870 | 0.050 |
Why?
| | Dexamethasone | 1 | 2024 | 370 | 0.050 |
Why?
| | Bile Acids and Salts | 1 | 2023 | 200 | 0.050 |
Why?
| | Vision Disorders | 1 | 2023 | 142 | 0.050 |
Why?
| | Electroretinography | 1 | 2021 | 48 | 0.040 |
Why?
| | Growth Charts | 1 | 2019 | 14 | 0.040 |
Why?
| | Syndrome | 1 | 2020 | 358 | 0.040 |
Why?
| | Anthropometry | 1 | 2019 | 213 | 0.040 |
Why?
| | Area Under Curve | 1 | 2019 | 314 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2077 | 0.040 |
Why?
| | Risk Assessment | 2 | 2019 | 3461 | 0.040 |
Why?
| | Retina | 1 | 2021 | 298 | 0.040 |
Why?
| | Immunity, Maternally-Acquired | 1 | 2018 | 19 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2010 | 7637 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2019 | 399 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2023 | 2041 | 0.040 |
Why?
| | Pedigree | 1 | 2019 | 514 | 0.040 |
Why?
| | Parity | 1 | 2017 | 126 | 0.030 |
Why?
| | Craniocerebral Trauma | 1 | 2019 | 170 | 0.030 |
Why?
| | Registries | 1 | 2024 | 2041 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2022 | 744 | 0.030 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2016 | 20 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2734 | 0.030 |
Why?
| | Risk | 1 | 2018 | 912 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2023 | 3290 | 0.030 |
Why?
| | Transplantation, Homologous | 1 | 2016 | 416 | 0.030 |
Why?
| | Optic Atrophy | 1 | 2015 | 8 | 0.030 |
Why?
| | Nutrition Disorders | 1 | 2014 | 23 | 0.030 |
Why?
| | Disease Progression | 1 | 2022 | 2760 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 6771 | 0.030 |
Why?
| | Viral Load | 1 | 2016 | 469 | 0.030 |
Why?
| | Hematologic Neoplasms | 1 | 2016 | 156 | 0.030 |
Why?
| | Photography | 1 | 2014 | 96 | 0.030 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2017 | 257 | 0.030 |
Why?
| | Awards and Prizes | 1 | 2014 | 67 | 0.030 |
Why?
| | Livedo Reticularis | 1 | 2013 | 4 | 0.030 |
Why?
| | Fetus | 1 | 2018 | 806 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1062 | 0.030 |
Why?
| | Autistic Disorder | 1 | 2014 | 204 | 0.020 |
Why?
| | Models, Statistical | 1 | 2016 | 669 | 0.020 |
Why?
| | Aged | 1 | 2010 | 24001 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3196 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 5793 | 0.020 |
Why?
| | Middle Aged | 1 | 2010 | 33554 | 0.020 |
Why?
| | Models, Biological | 1 | 2016 | 1783 | 0.020 |
Why?
| | Brain | 1 | 2019 | 2677 | 0.020 |
Why?
| | Mice | 1 | 2024 | 17794 | 0.020 |
Why?
| | Prospective Studies | 1 | 2019 | 7623 | 0.020 |
Why?
| | Animals | 1 | 2024 | 36951 | 0.010 |
Why?
|
|
McCourt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|